Source:http://linkedlifedata.com/resource/pubmed/id/10037247
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1999-3-3
|
pubmed:abstractText |
A decrease of GH levels below 2 microg/l after an oral glucose tolerance test (OGTT) is still currently accepted as the gold standard for assessing cure in surgically treated acromegaly. Whether glucose-induced suppression of GH is accompanied by a restoration of normal GH late rebound has not yet been evaluated in this disease. In order to assess the restoration of normal GH regulation after removal of a pituitary adenoma, we have evaluated GH changes after an OGTT in a series of selected acromegalic patients (transsphenoidal surgery and lack of pituitary failure).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0804-4643
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
140
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
23-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10037247-Acromegaly,
pubmed-meshheading:10037247-Adult,
pubmed-meshheading:10037247-Aged,
pubmed-meshheading:10037247-Blood Glucose,
pubmed-meshheading:10037247-Female,
pubmed-meshheading:10037247-Glucose Tolerance Test,
pubmed-meshheading:10037247-Growth Hormone,
pubmed-meshheading:10037247-Humans,
pubmed-meshheading:10037247-Insulin-Like Growth Factor I,
pubmed-meshheading:10037247-Male,
pubmed-meshheading:10037247-Middle Aged,
pubmed-meshheading:10037247-Time Factors,
pubmed-meshheading:10037247-Treatment Outcome
|
pubmed:year |
1999
|
pubmed:articleTitle |
Neurosurgery restores late GH rise after glucose-induced suppression in cured acromegalics.
|
pubmed:affiliation |
Department of Endocrinology, Niguarda Hospital, Milan, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|